Method of treating prostate cancer with the gnrh antagonist degarelix

Method of treating prostate cancer with the gnrh antagonist degarelix

  • CN 101,998,861 A
  • Filed: 02/10/2009
  • Published: 03/30/2011
  • Est. Priority Date: 02/11/2008
  • Status: Active Application
First Claim
Patent Images

1. compositions, it adds Rake with comprising, is used for the treatment of the carcinoma of prostate among the experimenter, and described treatment has the incidence rate and/or the probability of the minimizing of the side effect except that the injection site related side effects.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×